Literature DB >> 8468048

Molecular cloning of the b subunit of mouse coagulation factor XIII and assignment of the gene to chromosome 1: close evolutionary relationship to complement factor H.

M Nonaka1, Y Matsuda, T Shiroishi, K Moriwaki, M Nonaka1, S Natsuume-Sakai.   

Abstract

The b subunit of human coagulation factor XIII (FXIII-b) is composed of 10 short consensus repeats (SCRs) characteristic of the regulatory proteins of complement activation system. A full-length cDNA clone of mouse FXIII-b was isolated and the entire sequence was determined. The predicted amino acid sequence showed 77.5% homology with human FXIII-b, although mouse FXIII-b contained seven extra amino acid residues at the carboxyl terminal. The strong reactivity of the translation product of this clone with rabbit anti-human FXIII-b antiserum confirmed that it encodes a mouse counterpart of the human FXIII-b. By in situ hybridization and mapping studies using 66 interspecific backcross mice, the mouse FXIII-b gene (designated F13b) was shown to be located on distal chromosome 1 closely linked to Cfh, extending a conserved linkage group between human and mouse chromosome 1. In addition, a significant structural similarity between FXIII-b and complement factor H is described.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8468048     DOI: 10.1006/geno.1993.1106

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  2 in total

1.  Administration of factor XIII B subunit increased plasma factor XIII A subunit levels in factor XIII B subunit knock-out mice.

Authors:  Masayoshi Souri; Shiori Koseki-Kuno; Naoki Takeda; Jay L Degen; Akitada Ichinose
Journal:  Int J Hematol       Date:  2007-12-05       Impact factor: 2.490

2.  The NEI/NCBI dbGAP database: genotypes and haplotypes that may specifically predispose to risk of neovascular age-related macular degeneration.

Authors:  Hong Zhang; Margaux A Morrison; Andy Dewan; Scott Adams; Michael Andreoli; Nancy Huynh; Maureen Regan; Alison Brown; Joan W Miller; Ivana K Kim; Josephine Hoh; Margaret M Deangelis
Journal:  BMC Med Genet       Date:  2008-06-09       Impact factor: 2.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.